HealthDay

Individualized Medical-Nutrition Therapy Important in Diabetes

TUESDAY, April 23, 2019 (Pharmacist's Briefing) -- Diabetes-focused medical nutrition therapy (MNT) is fundamental to overall diabetes management and should be adapted as needed throughout life, according to a consensus report published in the May issue of Diabetes Care

Read More

HealthDay

Outcomes Worse for Cancer Patients Seen at Noncancer EDs

TUESDAY, April 23, 2019 (Pharmacist's Briefing) -- Patients with cancer who are seeking cancer-related emergency medical care have worse outcomes when they are seen at alternative hospitals or those not associated with a cancer center, according to a study published in the April 23 issue of CMAJ, the journal of the Canadian Medical Association

Read More

HealthDay

What Your Patients Are Reading

'Two Wave' Flu Season Unusually Long: CDC

TUESDAY, April 23, 2019 (Pharmacist's Briefing) -- What looked like a mild flu season in December has turned into the longest flu season in five years, U.S. health officials report

Read More

HealthDay

Hot Topics

Risks, Benefits of Long-Term Drug Therapy for Osteoporosis Reviewed

TUESDAY, April 23, 2019 (Pharmacist's Briefing) -- Long-term osteoporosis drug therapy (ODT) reduces fracture risk in women but may increase risk for rare adverse events, and research gaps surround use of long-term drug therapies for osteoporotic fracture prevention, according to a review and position paper published online April 23 in the Annals of Internal Medicine

Read More

HealthDay

Industry News You Can Use

FDA Approves Pembrolizumab Plus Axitinib for Advanced RCC

TUESDAY, April 23, 2019 (Pharmacist's Briefing) -- The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma (RCC), the U.S. Food and Drug Administration announced Friday

Read More